Claritev (NYSE:CTEV – Get Free Report) CEO Travis Dalton bought 1,950 shares of the business’s stock in a transaction dated Friday, August 28th. The stock was acquired at an average cost of $38.48 per share, for a total transaction of $75,036.00. Following the purchase, the chief executive officer owned 52,322 shares in the company, valued at approximately $2,013,350.56. This trade represents a 3.87% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Travis Dalton also recently made the following trade(s):
- On Thursday, August 27th, Travis Dalton purchased 4,500 shares of Claritev stock. The shares were acquired at an average cost of $38.81 per share, with a total value of $174,645.00.
Claritev Price Performance
NYSE:CTEV opened at $39.98 on Thursday. The business’s 50-day moving average is $31.81 and its two-hundred day moving average is $25.14. Claritev has a 12 month low of $11.50 and a 12 month high of $74.07. The firm has a market capitalization of $677.66 million, a PE ratio of -2.35 and a beta of 0.88.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Claritev in a report on Wednesday, June 24th. Zacks Research raised shares of Claritev from a “strong sell” rating to a “hold” rating in a research report on Thursday, August 13th. Citigroup reiterated a “buy” rating and issued a $45.00 price target (up from $40.00) on shares of Claritev in a research note on Monday, August 10th. Barclays reaffirmed an “overweight” rating and set a $40.00 target price (up from $28.00) on shares of Claritev in a report on Thursday, August 20th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $73.00 price target on shares of Claritev in a report on Wednesday, August 12th. Six equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $44.83.
Check Out Our Latest Analysis on Claritev
Hedge Funds Weigh In On Claritev
A number of large investors have recently bought and sold shares of the business. Public Investment Fund acquired a new stake in shares of Claritev during the 2nd quarter worth approximately $43,703,438. Arini Captial Management Ltd acquired a new position in Claritev during the 4th quarter valued at approximately $64,291,000. Beach Point Capital Management LP grew its stake in Claritev by 77.4% during the 4th quarter. Beach Point Capital Management LP now owns 755,002 shares of the company’s stock worth $32,276,000 after buying an additional 329,424 shares during the last quarter. State of Wyoming bought a new position in Claritev during the 4th quarter worth $25,000. Finally, California State Teachers Retirement System increased its position in Claritev by 798.0% in the second quarter. California State Teachers Retirement System now owns 4,400 shares of the company’s stock worth $150,000 after buying an additional 3,910 shares during the period. Institutional investors own 87.15% of the company’s stock.
About Claritev
Claritev is a healthcare technology, data and insights company focused on improving affordability, transparency and quality. Led by deeply experienced associates, data scientists, and innovators, Claritev provides tech-enabled solutions and services fueled by multiple data sources from over 40 years of claims repricing. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design.
Featured Stories
- Five stocks we like better than Claritev
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Receive News & Ratings for Claritev Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Claritev and related companies with MarketBeat.com's FREE daily email newsletter.
